Which scenario would most strongly argue against performing a bone biopsy based on imaging?

Which scenario would most strongly argue against performing a bone biopsy based on imaging?

• A. Imaging suggests a bone biopsy could precipitate pathologic fracture
• B. Imaging shows a clearly benign lesion
• C. Imaging shows normal bone
• D. Imaging shows a metastatic lesion with obvious boundary

Answer: (A)

The key idea is weighing the safety of a bone biopsy against the potential diagnostic benefit based on imaging. If imaging suggests that the biopsy could weaken the bone enough to cause a pathologic fracture, that risk becomes a strong argument against proceeding with the biopsy. The structural integrity of the affected bone is compromised by the lesion; inserting a needle or taking a core sample could tip the balance to fracture, which is a serious harm that can outweigh the value of obtaining a tissue diagnosis. Other scenarios are less compelling reasons to withhold biopsy. Seeing a clearly benign lesion on imaging might lead you to opt for observation rather than biopsy, but it doesn’t pose the immediate, high-stakes harm of a fracture. Normal bone imaging makes biopsy unnecessary, but that is a lack of indication rather than a direct safety concern. A metastatic lesion with a well-defined boundary doesn’t automatically preclude biopsy; if histology would change management, a biopsy might still be pursued, though the fracture risk would need careful consideration.

The key idea is weighing the safety of a bone biopsy against the potential diagnostic benefit based on imaging. If imaging suggests that the biopsy could weaken the bone enough to cause a pathologic fracture, that risk becomes a strong argument against proceeding with the biopsy. The structural integrity of the affected bone is compromised by the lesion; inserting a needle or taking a core sample could tip the balance to fracture, which is a serious harm that can outweigh the value of obtaining a tissue diagnosis.

Other scenarios are less compelling reasons to withhold biopsy. Seeing a clearly benign lesion on imaging might lead you to opt for observation rather than biopsy, but it doesn’t pose the immediate, high-stakes harm of a fracture. Normal bone imaging makes biopsy unnecessary, but that is a lack of indication rather than a direct safety concern. A metastatic lesion with a well-defined boundary doesn’t automatically preclude biopsy; if histology would change management, a biopsy might still be pursued, though the fracture risk would need careful consideration.